Former Theranos president Sunny Balwani convicted of fraud
Balwani was found guilty of all charges against him for his role in the collapse of the $9bn blood-testing start-up
07 July 2022 - 23:40
byJody Godoy
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Sunny Balwani, former president of Theranos, leaves the federal court in San Jose, California, the US, July 7 2022. Picture: DAVID PAUL MORRIS/BLOOMBEG
A US jury on Thursday convicted former Theranos President Ramesh “Sunny” Balwani of defrauding investors and patients about the blood testing start-up that was once valued at $9bn.
The San Jose, California, jury deliberated for a little more than five days before convicting Balwani on two counts of conspiracy and 10 counts of fraud, a spokesperson for US attorney Stephanie Hinds said. Sentencing was scheduled for November 15.
Theranos founder Elizabeth Holmes, who initially faced the same charges, was convicted on three counts of fraud and one count of conspiracy at a separate trial in January. She is scheduled to be sentenced on September 26.
They were granted separate trials after Holmes said she would testify that Balwani was abusive towards her in their romantic relationship. Balwani denied the allegations.
“We are gratified by the jury’s hard work and attentiveness to the evidence presented,” Hinds said in a statement. “We appreciate the verdict and look forward to sentencing proceedings.”
Balwani’s attorney, Jeffrey Coopersmith, said the defence was “obviously disappointed with the verdicts” and would consider all options including an appeal.
Balwani and Holmes were charged in 2018 with lying to investors about the company’s finances and its machines’ ability to run a broad range of tests from a few drops of blood. Prosecutors also charged the pair with duping patients about the tests’ accuracy.
Theranos investors were drawn to Holmes and her promise to upend the laboratory testing industry by creating portable machines that could run a broad array of tests.
The company touted work with drugmakers, pharmacies and the US military and received investments from media mogul Rupert Murdoch.
Theranos collapsed after the Wall Street Journal published a series of articles, starting in 2015, that suggested its devices were flawed and inaccurate.
At trial, Holmes made the somewhat unusual decision to testify in her own defence and denied lying to investors. She has argued that the evidence was insufficient to support the verdict.
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Former Theranos president Sunny Balwani convicted of fraud
Balwani was found guilty of all charges against him for his role in the collapse of the $9bn blood-testing start-up
A US jury on Thursday convicted former Theranos President Ramesh “Sunny” Balwani of defrauding investors and patients about the blood testing start-up that was once valued at $9bn.
The San Jose, California, jury deliberated for a little more than five days before convicting Balwani on two counts of conspiracy and 10 counts of fraud, a spokesperson for US attorney Stephanie Hinds said. Sentencing was scheduled for November 15.
Theranos founder Elizabeth Holmes, who initially faced the same charges, was convicted on three counts of fraud and one count of conspiracy at a separate trial in January. She is scheduled to be sentenced on September 26.
They were granted separate trials after Holmes said she would testify that Balwani was abusive towards her in their romantic relationship. Balwani denied the allegations.
“We are gratified by the jury’s hard work and attentiveness to the evidence presented,” Hinds said in a statement. “We appreciate the verdict and look forward to sentencing proceedings.”
Balwani’s attorney, Jeffrey Coopersmith, said the defence was “obviously disappointed with the verdicts” and would consider all options including an appeal.
Balwani and Holmes were charged in 2018 with lying to investors about the company’s finances and its machines’ ability to run a broad range of tests from a few drops of blood. Prosecutors also charged the pair with duping patients about the tests’ accuracy.
Theranos investors were drawn to Holmes and her promise to upend the laboratory testing industry by creating portable machines that could run a broad array of tests.
The company touted work with drugmakers, pharmacies and the US military and received investments from media mogul Rupert Murdoch.
Theranos collapsed after the Wall Street Journal published a series of articles, starting in 2015, that suggested its devices were flawed and inaccurate.
At trial, Holmes made the somewhat unusual decision to testify in her own defence and denied lying to investors. She has argued that the evidence was insufficient to support the verdict.
Reuters
KATE THOMPSON DAVY: Holmes is where the art of fraud is
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Most Read
Related Articles
KATE THOMPSON DAVY: Beware the tech hype trap: Theranos and Elizabeth Holmes go ...
Theranos fraud trial gets under way with jurors grilled on impartiality
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.